BEN vs DMAC · P/E 36, rev $8.77B vs $157.4M cap
Franklin Resources Inc (BEN) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Franklin Resources Inc (BEN) is a asset management company listed on US.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
DMAC does not have a complete income-statement cache yet.
BEN currently screens at market cap $13.09B and trailing P/E 35.6. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the BEN and DMAC stock pages for the full models.
Not investment advice.